Lantheus Holdings, Inc.

LNTH ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › Balance Sheet
Annual Quarterly

Balance Sheet

Line Item FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019 FY2018
Assets
Cash & Equivalents $359.1M $912.8M $713.7M $415.7M $98.5M $79.6M $92.9M $113.4M
Accounts Receivable $358.6M $321.3M $284.3M $213.4M $89.3M $54.0M $43.5M $43.8M
Inventory $64.7M $68.0M $64.0M $35.5M $35.1M $35.7M $29.2M $33.0M
Total Current Assets $900.0M $1.33B $1.09B $677.6M $235.8M $184.2M $172.9M $195.4M
Property, Plant & Equipment $163.7M $176.8M $146.7M $122.2M $116.8M $120.2M $116.5M $107.9M
Goodwill $239.5M $61.2M $61.2M $61.2M $61.2M $58.6M $15.7M $15.7M
Intangible Assets (Excl. Goodwill) $722.8M $161.8M $152.0M $315.3M $348.5M $376.0M $7.3M $9.1M
Total Assets $2.23B $1.98B $1.65B $1.32B $863.8M $869.8M $405.9M $439.8M
Liabilities
Accounts Payable $42.9M $34.6M $41.2M $20.6M $20.8M $16.3M $18.6M $18.0M
Total Current Liabilities $333.4M $240.5M $187.4M $247.7M $90.5M $80.5M $66.1M $52.8M
Long-Term Debt $568.7M $565.3M $561.7M $557.7M $163.1M $197.7M $183.9M $263.7M
Total Liabilities $1.14B $892.3M $835.3M $874.1M $399.3M $355.6M $291.3M $368.8M
Stockholders' Equity
Retained Earnings $679.5M $445.9M $133.5M $-193.2M $-221.2M $-149.9M $-136.5M $-168.1M
Total Stockholders' Equity $1.09B $1.09B $815.9M $447.1M $464.4M $514.2M $114.6M $71.0M
← Newer Page 1 of 2 Older →